$ELTX

$1.83 +$0.13 (7.65%) Close

$ELTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 26.3M shares outstanding

Who owns ELTX?

By type of holder

Institutions 14.9% Insiders 22.1% Everyone else 62.9%

Concentration Top 10 holders own 87.5%

Yekaterina Chudnovsky 37.2% · GKCC, LLC 37.1%

Institutional ownership

14.9%

+4.9 pts vs last qtr

Institutional holders

+1 vs last qtr

Net shares bought

+1.3M

by institutions in Q2 2026

New / sold out

24 / 23

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +715.4K
Knoll Capital Management, LLC +581.0K

Biggest sellers in Q2 2026

Balyasny Asset Management L.P. SOLD OUT −244.8K
Renaissance Technologies LLC SOLD OUT −121.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Elicio Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+202.8%

+74.03% a year

Each share's claim on the business

−67.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $5.33M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years29% 1–3 years59% Under 1 year12%

Quarterly turnover

61.0%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting ELTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
KC Knoll Capital Management, LLC	1.2M	4.61%	+581.0K (+92.1%)	2025	2.2%
Shares held by quarter Peak holding1.2M (Q2'26) Change over 8 quarters+1.2M Share of the company4.610% Knoll Capital Management, LLC's full portfolio →
B BlackRock, Inc.	766.0K	2.91%	+715.4K (+1413.9%)	2023	0.0%
Shares held by quarter Peak holding766.0K (Q2'26) Change over 8 quarters+746.3K Share of the company2.910% BlackRock, Inc.'s full portfolio →

Knoll Capital Management, LLC

1.2M

% of company

4.61%

Change vs last qtr

+581.0K (+92.1%)

Held since

2025

BlackRock, Inc.

766.0K

% of company

2.91%

Change vs last qtr

+715.4K (+1413.9%)

Held since

2023

28 more super investors behind a free account

See every manager holding Elicio Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ELTX on Form N-PORT; together they hold 5.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$1.62M	415.4K	1.58%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$1.25M	318.8K	1.21%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$1.62M

% of company

1.58%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$1.25M

% of company

1.21%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Elicio Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
YC Yekaterina Chudnovsky 5%+ holder 13D · 48.0%	9.8M	37.15%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company37.150% Disclosed stake13D · 48.0% View the 13D/G filing →
G GKCC, LLC 5%+ holder 13D · 48.0%	9.8M	37.11%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company37.110% Disclosed stake13D · 48.0% View the 13D/G filing →

Yekaterina Chudnovsky

5%+ holder13D · 48.0%

9.8M

% of company

37.15%

Change vs last qtr

—

Held since

—

GKCC, LLC

5%+ holder13D · 48.0%

9.8M

% of company

37.11%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Elicio Therapeutics Inc.

Comments